Alzheimer's disease: new therapies and the role of biomarkers.
Year: 2011
Type: article
Abstract: Biomarkers have shown promise for identifying people at high risk for Alzheimer's disease. Therapies that address presymptomatic disease are already in development, and MCOs should start thinking about coverage for them.
Source: PubMed
Author: Kellie Dudash
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1577219674
